Silexion Therapeutics Corp - SLXN
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | History | Closed out | 0 | 0 | — | 0.0% | — | -12,205 | -100.0% | Q4 2025 | Feb 17, 2026 |
| MONTAG A & ASSOCIATES INC | History | Closed out | 0 | 0 | — | 0.0% | — | -3,000 | -100.0% | Q4 2025 | Feb 02, 2026 |
| UBS Group AG | History | Closed out | 0 | 0 | — | 0.0% | — | -1,691 | -100.0% | Q4 2025 | Jan 29, 2026 |
| SBI Securities Co., Ltd. | History | Closed out | 0 | 0 | — | 0.0% | — | -1,060 | -100.0% | Q4 2025 | Feb 03, 2026 |
| JONES FINANCIAL COMPANIES LLLP | History | Closed out | 0 | 0 | — | — | — | -26 | -100.0% | Q4 2025 | Feb 17, 2026 |
| Pflug Koory, LLC | History | No change | 333 | 0 | — | — | — | 0 | 0.0% | Q1 2026 | Apr 21, 2026 |